Gulf Islamic Investments (GII) has made investments in the $200+ billion Indian healthcare sector by buying a significant minority stake in a portfolio of healthcare companies, including a virus test manufacturing company.
This is part of several planned investments by GII in healthcare, with multiple opportunities already in the pipeline across the US, Europe and India and its existing investments in Healthcare wearable space – Valencell and Nymi – where GII is a significant investor, said a statement.
Healthcare has been identified by GII as an attractive, non-cyclical and growing sector propelled by several trends such as ageing, lifestyle diseases, and lately the Covid-19 pandemic.
Driven by strong tailwinds – the sector growing in India by 15-20% per year, increasing government healthcare expenditure, a shortfall of 2.5 million hospital beds, and health insurance coverage expected to grow by 23% per year until 2024 – the investment is expected to generate attractive returns, it says.
Mohammed Al-Hassan, Co-Founder & CEO GCC at Gulf Islamic Investments, comments: “We are delighted to introduce new and unique investments to our clients. This opportunity has diversified our portfolio of investments. India has immense market potential for the Healthcare industry, and we are positive that investing with a leading company in India will have a rewarding outcome for our investors.”
Pankaj Gupta, Co-Founder & CEO UAE at Gulf Islamic Investments, says: “Entering the healthcare sector in one of the largest populated countries in the world is a tremendous achievement for GII. Our strategy in investing in one of the fastest growing industries in India reflects GII’s capabilities of providing high quality investments to its client base. We see future potential in India’s Healthcare Industry and believe that we will add value through our investment to our valued client base.” –TradeArabia News Service